SARquavitae
Who owns SARquavitae?
SARquavitae is a British Healthcare company, now owned by DomusVi, which acquired it in 2017 from Palamon Capital Partners and G Square Healthcare PE.
Hand-verified · updated 2026-09-30
Open JSON · CC-BYKey facts
- ·Fully exited in 2017 to DomusVi.
- ·Average hold across 2 realized cycles: 8 years.
Ownership history
2 ownership periods · co-invest detected
Palamon Capital Partners sold SARquavitae to DomusVi in 2017 after 8 years.
G Square Healthcare PE sold SARquavitae to HomeVi in 2017 after 8 years.
More from G Square Capital I
Other portfolio companies in the same fund.
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
Questions
Who owns SARquavitae?
SARquavitae is now owned by DomusVi, which acquired it in 2017 from Palamon Capital Partners and G Square Healthcare PE.
When did DomusVi acquire SARquavitae?
DomusVi acquired SARquavitae in 2017, buying from Palamon Capital Partners and G Square Healthcare PE.
Who did SARquavitae sell to?
Palamon Capital Partners sold SARquavitae to DomusVi in 2017 (Trade Sale). G Square Healthcare PE sold SARquavitae to HomeVi in 2017 (Trade Sale).
Who has owned SARquavitae over time?
SARquavitae has been through 2 private-equity ownership periods: Palamon Capital Partners · via Palamon European Equity Fund II LP · 2009–2017 · sold to DomusVi · (Trade Sale); G Square Healthcare PE · via G Square Capital I · 2009–2017 · sold to HomeVi · (Trade Sale).